本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

23.51
-0.7600-3.13%
成交量:345.93萬
成交額:8,144.13萬
市值:29.40億
市盈率:109.14
高:24.28
開:24.23
低:23.10
收:24.27
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:1.36
換手率:3.11%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:13.33
市盈率(LYR):-185.32

資料載入中...

2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities